Introduction: Emergence delirium is a state of aggressive delirium that can occur temporarily in the process of emerging from anaesthesia, and occurs most often during the early stages of emergence1. Newer volatile agents like sevourane and desurane are said to have a 20-80% increased incidence of adverse emergence effects when compared to halothane and isourane. This study was undertaken with the Aims And Objectives: aim of prospectively comparing the incidence of emergence agitation between sevourane and desurane in pediatric patients. To compare the pain intensity at 10 minutes, 20 minutes, 30 minutes, 45 minutes, 1 hour and 2 hours. To compare the time for tracheal extubation after discontinuing volatile agents in both groups. This prospective randomized control study study was c Materials And Methods: arried out in 60 pediatric patients between the age group 3-12 years undergoing elective surgeries under general anaesthesia. Patients were randomized into the following 2 groups: GROUP S - Anaesthesia was maintained with oxygen, nitrous oxide and sevourane (MAC 1). GROUP D - Anaesthesia was maintained with oxygen, nitrous oxide and desurane (MAC 1). Comparison between Age, gender, ASA, weights, D Results: uration of Inhalation Exposure(mins), Time for Extubation after discontinuing volatile(mins), PAED Score with Groups by Mann- Whitney U test, VAS Score with Groups by Unpaired ttest with Groups shows no statistical signicant association. Des Conclusion: urane has faster recovery from anaesthesia when compared to sevourane in pediatric patients. Incidence of emergence agitation is comparable between both the groups although sevourane has a slightly higher incidence of EA than desurane in our study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.